Chronic pruritus: A paraneoplastic sign

Research output: Contribution to journalReview articlepeer-review

48 Scopus citations

Abstract

Chronic itch could be a presenting sign of malignancy. Pruritus of lymphoma is the common prototype of paraneoplastic itch and can precede other clinical signs by weeks and months. Paraneoplastic pruritus has also been associated with solid tumors and is an important clinical symptom in paraneoplastic skin diseases such as erythroderma, Grovers disease, malignant acanthosis nigricans, generalized granuloma annulare, Bazex syndrome, and dermatomyositis. In any case with high index of suspicion a thorough work-up is required. This review highlights the association between itch and malignancy and presents new findings related to pathophysiological mechanisms and the treatment of itch associated with malignancy. Combinative therapies reducing itch sensitization and transmission using selective serotonin and neuroepinephrine reuptake inhibitors, Kappa opioids, and neuroleptics are of prime importance in reducing this bothersome symptom.

Original languageEnglish (US)
Pages (from-to)590-596
Number of pages7
JournalDermatologic Therapy
Volume23
Issue number6
DOIs
StatePublished - Nov 2010

Keywords

  • itch pathophysiology
  • kappa opioids
  • neuroleptics
  • paraneoplastic itch

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Chronic pruritus: A paraneoplastic sign'. Together they form a unique fingerprint.

Cite this